Related references
Note: Only part of the references are listed.In Vitro Effects of Rituximab on the Proliferation, Activation and Differentiation of Human B Cells
E. G. Kamburova et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
Sebastian Eickenberg et al.
ARTHRITIS RESEARCH & THERAPY (2012)
The Anti-CD20 Antibody Rituximab Reduces the Th17 Cell Response
Frank L. van de Veerdonk et al.
ARTHRITIS AND RHEUMATISM (2011)
Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells
Yohei Iwata et al.
BLOOD (2011)
Immunologic effects of rituximab on the human spleen in immune thrombocytopenia
Sylvain Audia et al.
BLOOD (2011)
B-cell immunotherapeutics: emerging roles in solid organ transplantation
Stanley C. Jordan et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2011)
Loss of CD20 and Bound CD20 Antibody from Opsonized B Cells Occurs More Rapidly Because of Trogocytosis Mediated by Fc Receptor-Expressing Effector Cells Than Direct Internalization by the B Cells
Paul V. Beum et al.
JOURNAL OF IMMUNOLOGY (2011)
Effect of Single-Dose Rituximab on Primary Glomerular Diseases
Hidekazu Sugiura et al.
NEPHRON CLINICAL PRACTICE (2011)
Primary B-Cell Deficiencies Reveal a Link between Human IL-17-Producing CD4 T-Cell Homeostasis and B-Cell Differentiation
Rita R. Barbosa et al.
PLOS ONE (2011)
The 5-Year Outcome of ABO-Incompatible Kidney Transplantation With Rituximab Induction
Shohei Fuchinoue et al.
TRANSPLANTATION (2011)
Abnormal B-Cell Cytokine Responses A Trigger of T-Cell Mediated Disease in MS?
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2010)
Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
Stephen A. Beers et al.
BLOOD (2010)
Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximab
Martin Wermke et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
CD19+CD24hiCD38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals but Are Functionally Impaired in Systemic Lupus Erythematosus Patients
Paul A. Blair et al.
IMMUNITY (2010)
Identification of a B cell signature associated with renal transplant tolerance in humans
Kenneth A. Newell et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Use of Intravenous Immune Globulin and Rituximab for Desensitization of Highly HLA-Sensitized Patients Awaiting Kidney Transplantation
Ashley A. Vo et al.
TRANSPLANTATION (2010)
Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
Thomas Doerner et al.
AUTOIMMUNITY REVIEWS (2009)
Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production
S. Heidt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Collapse of the CD27+B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other Cancers
Erica L. Carpenter et al.
CLINICAL CANCER RESEARCH (2009)
Resting Human Memory B Cells Are Intrinsically Programmed for Enhanced Survival and Responsiveness to Diverse Stimuli Compared to Naive B Cells
Kim L. Good et al.
JOURNAL OF IMMUNOLOGY (2009)
Rituximab therapy reduces activated B cells in both the peripheral blood and bone marrow of patients with rheumatoid arthritis: depletion of memory B cells correlates with clinical response
Magda Nakou et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells
Hans J. P. M. Koenen et al.
BLOOD (2008)
IL-21-induced isotype switching to IgG and IgA by human naive B cells is differentially regulated by IL-4
Danielle T. Avery et al.
JOURNAL OF IMMUNOLOGY (2008)
B cell survival in intragraft tertiary lymphoid organs after rituximab therapy
Olivier Thaunat et al.
TRANSPLANTATION (2008)
Synovial tissue response to rituximab: mechanism of action and identification of biomarkers of response
R. M. Thurlings et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Mechanisms of killing by anti-CD20 monoclonal antibodies
Martin J. Glennie et al.
MOLECULAR IMMUNOLOGY (2007)
Rituximab therapy for acute humoral rejection after kidney transplantation
Stanislas Faguer et al.
TRANSPLANTATION (2007)
Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis
Koen Vos et al.
ARTHRITIS AND RHEUMATISM (2007)
The effect of desensitization protocols on human splenic B-cell populations in vivo
E. J. Ramos et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Pharmacodynamics of rituximab in kidney allotransplantation
H. Genberg et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab
G Tyden et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia
AD Kennedy et al.
JOURNAL OF IMMUNOLOGY (2004)
A new anti-idiotype antibody capable of binding rituximab on the surface of lymphoma cells
MS Cragg et al.
BLOOD (2004)
Apparent modulation of CD20 by rituximab: an alternative explanation
MS Cragg et al.
BLOOD (2004)
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia
I Jilani et al.
BLOOD (2003)
B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion
E Barbera-Guillem et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
Share Paper
